Capital Appropriations

One man’s plan for high-concept health care legislation.

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily.


After watching the city’s spending on drugs for Medicaid recipients and municipal employees rise 256 percent during his seven-year tenure, Washington, D.C., City Council member David Catania came up with a plan for high-concept health care legislation. His law? That the city can invoke eminent domain over drug patents, then make the drugs available as cheaper generics.

It’s not as far-fetched as it sounds. For decades, the United States has used eminent domain to issue compulsory licenses in the defense industry. Patent holders get “just compensation” —such as the 1 percent royalty Hughes Aircraft made on its satellite technology after the courts ruled that 15 percent, or $3.3 billion, was excessive. The same could happen in health care. During the 2001 anthrax scare, Health and Human Services Secretary Tommy Thompson threatened to ignore Bayer’s Cipro patent to get hold of a cheaper generic; Bayer ended up boosting production and cutting the price.

Under pressure from businesses, Catania was undaunted. He rewrote the measure, minus the eminent domain language, and instead drew on the city’s powers to protect consumers. On a first vote, the council unanimously supported the new bill, which would allow residents to sue a drug company for “excessive prices,” when compared with those in Canada and elsewhere. If he can win this one in a final vote this summer—a big if, we know, since many great artists enjoy little success during their lifetimes—and a judge rules a drug is too pricey, the court could issue a compulsory license, authorizing the city to turn to another manufacturer.

Plus, Catania’s idea isn’t just high-concept; it’s virtual, since, he claims, the district would never have to enforce it. Drug companies would preemptively negotiate with the city to stay out of the courts, explains Catania. “They’ll do anything they possibly can to avoid discussing how they price their drugs,” he says. His constituents, meanwhile, would celebrate the bargains.

PLEASE—BEFORE YOU CLICK AWAY!

“Lying.” “Disgusting.” “Scum.” “Slime.” “Corrupt.” “Enemy of the people.” Donald Trump has always made clear what he thinks of journalists. And it’s plain now that his administration intends to do everything it can to stop journalists from reporting things it doesn’t like—which is most things that are true.

We’ll say it loud and clear: At Mother Jones, no one gets to tell us what to publish or not publish, because no one owns our fiercely independent newsroom. But that also means we need to directly raise the resources it takes to keep our journalism alive. There’s only one way for that to happen, and it’s readers like you stepping up. Please do your part and help us reach our $150,000 membership goal by May 31.

payment methods

PLEASE—BEFORE YOU CLICK AWAY!

“Lying.” “Disgusting.” “Scum.” “Slime.” “Corrupt.” “Enemy of the people.” Donald Trump has always made clear what he thinks of journalists. And it’s plain now that his administration intends to do everything it can to stop journalists from reporting things it doesn’t like—which is most things that are true.

We’ll say it loud and clear: At Mother Jones, no one gets to tell us what to publish or not publish, because no one owns our fiercely independent newsroom. But that also means we need to directly raise the resources it takes to keep our journalism alive. There’s only one way for that to happen, and it’s readers like you stepping up. Please do your part and help us reach our $150,000 membership goal by May 31.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate